Positron emission tomography (PET) with [18 F] 2-fluoro-2-deoxy-D-glucose (FDG) may
show negative results for bronchioloalveolar lung carcinoma. We investigated the …

PURPOSE: To compare the accuracies of whole-body 2-[fluorine 18] fluoro-2-deoxy-d-
glucose (FDG) positron emission tomography (PET) and conventional imaging (thoracic …

The purpose of this study was to determine whether dual-phase 18F-FDG PET could be a
prognostic factor for adenocarcinoma of the lung. Methods: One hundred patients with …

Background. We evaluated the prognostic significance of standardized uptake value
(SUVmax), metabolic tumour volume (MTV), and total lesion glycolysis (TLG) in [F-18] FDG …

Cancer cells show increased metabolism of both glucose and amino acids, which can be
monitored with 18 F-2-deoxy-2-fluoro-d-glucose (FDG), a glucose analogue, and 11 Cl …

Background The outcome of surgical treatment of non-small-cell lung cancer (NSCLC)
remains poor. In many patients the biological behavior of NSCLC does not follow a definite …

Background Data from clinical trials suggest that changes in the glucose avidity of the
primary site of lung cancer during induction therapy, measured by changes in 18 F …

Study objective To evaluate the accuracy of positron emission tomography (PET) in
determining the presence of malignancy in patients presenting with new lung findings, either …

PURPOSE: To study the precision of repeated 2-[fluorine-18]-fluoro-2-deoxy-D-glucose
(FDG) uptake measurements at positron emission tomography (PET) in patients with primary …

In patients with clinical stage IA non-small cell lung cancer (NSCLC), we investigated
whether the maximum standardized uptake value (SUVmax) of 18F-fluorodeoxyglucose …